These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7678312)

  • 1. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.
    Wolinsky JS; McCarthy M; Allen-Cannady O; Moore WT; Jin R; Cao SN; Lovett A; Simmons D
    J Virol; 1991 Aug; 65(8):3986-94. PubMed ID: 1712855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.
    Cordoba P; Grutadauria SL; Cuffini C; Zapata MT
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):493-5. PubMed ID: 9220172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.
    Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M
    J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.
    Green KY; Dorsett PH
    J Virol; 1986 Mar; 57(3):893-8. PubMed ID: 2419590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.
    Lozzi L; Rustici M; Corti M; Cusi MG; Valensin PE; Bracci L; Santucci A; Soldani P; Spreafico A; Neri P
    Arch Virol; 1990; 110(3-4):271-6. PubMed ID: 1690535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.
    Ou D; Chong P; Tingle AJ; Gillam S
    J Med Virol; 1993 Jul; 40(3):175-83. PubMed ID: 7689090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin.
    Gerna G; Revello MG; Dovis M; Petruzzelli E; Achilli G; Percivalle E; Torsellini M
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():2007-12. PubMed ID: 2439653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.
    Cordoba P; Lanoel A; Grutadauria S; Zapata M
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):964-6. PubMed ID: 11063507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Babas T; Le Grand R; Dormont D; Bahraoui E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different affinity of monoclonal antibodies for conserved neutralizing epitopes on two strains of rubella virus.
    Cordoba P; Grutadauria S; Cuffini C; Zapata MT
    Viral Immunol; 1997; 10(2):103-10. PubMed ID: 9210284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterisation of the rubella E 1 glycoprotein. Brief report.
    Ho-Terry L; Terry GM; Cohen A; Londesborough P
    Arch Virol; 1986; 90(1-2):145-52. PubMed ID: 2425779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.